ANNE DEAN: Open Payments
NPI 1457926701 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 97 payments from 10 companies in 2025. Trend: 2023 $960 · 2024 $1,027 · 2025 $1,388
Food & beverage: $1,388
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 32 | $360 |
| E.R. Squibb & Sons, L.L.C. | 19 | $243 |
| Teva Pharmaceuticals USA, Inc. | 12 | $204 |
| Vanda Pharmaceuticals Inc. | 12 | $197 |
| Alkermes, Inc. | 11 | $172 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| ABBVIE INC. | 2 | $41 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: ABILIFY MAINTENA, COBENFY, FANAPT, ARISTADA, REXULTI, AUSTEDO XR, UZEDY, INGREZZA.
Industry payments across MI — which companies pay providers there.
